Evidence map›Paper›PMID 32360423›Full record

ArticleTravel medicine and infectious disease

Malaria prophylaxis approach during COVID-19 pandemic.

Natalia Rodriguez-Valero, Isabel Vera, Montse Roldan Torralvo, Teresa De Alba, Elisabeth Ferrer, Daniel Camprubi, Alex Almuedo Riera, Ruth Sotil Gallego, Magdalena Muelas, Maria Jesus Pinazo and 1 more

Abstract readLetter
In one paragraph

Article in Travel medicine and infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Natalia Rodriguez-ValeroISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain. Electronic address: natalia.rodriguez@isglobal.org.
Isabel VeraISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Montse Roldan TorralvoISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Teresa De AlbaISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Elisabeth FerrerISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Daniel CamprubiISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Alex Almuedo RieraISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Ruth Sotil GallegoISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Magdalena MuelasISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Maria Jesus PinazoISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Jose MuñozISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

SARS-CoV-2ChloroquineCOVID-19Drug ResistanceHumansHydroxychloroquineMalariaPre-Exposure ProphylaxisChloroquineHydroxychloroquine

Identifiers

PMID32360423
PMCPMC7252065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.